Medtronic completes MiniMed separation. Medtronic stock falls 1.35 percent

Published on 10/20/2026 at 10:13 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Medtronic exchanged 252,813,348 MiniMed shares on October 15, 2026. Medtronic stock costs EUR 83.20, 1.35 percent below the Xetra close.

Portfolio reset and earnings test

Medtronic completed its MiniMed separation on October 15, 2026, exchanging 252,813,348 shares.
First-quarter fiscal 2027 revenue reached USD 9.76 billion, up 13.70 percent year over year.
Medtronic stock trades at EUR 83.20 at 10:05 a.m. CEST at Lang & Schwarz on October 20, 2026, 1.35 percent below the Xetra close of October 19, 2026.
The next reporting date is November 17, 2026.

Aquarellmalerei der Dubliner Skyline entlang des Flusses Liffey in warmen Farben — Medtronic plc (ISIN IE00BTN1Y115) Aquarellbild zeigt die Skyline von Dublin entlang des Flusses Liffey stimmungsvoll, Illustration mit AI erstellt.

Medtronic plc (ISIN IE00BTN1Y115) completed its MiniMed separation on October 15, 2026, exchanging 252,813,348 MiniMed shares. The transaction leaves the medical technology group focused on its Cardiovascular, Neuroscience and Surgical portfolios, according to Medtronic.

Three dates shape the reset

On September 1, 2026, Medtronic reported first-quarter fiscal 2027 revenue of USD 9.76 billion, up 13.70 percent from the prior-year quarter, while adjusted earnings per share reached USD 1.45 versus USD 1.39 expected, according to MarketBeat. On October 12, 2026, Medtronic said 298,024,452 ordinary shares had been tendered in the exchange offer, according to Medtronic. The October 15 completion was the final step, with the offer 5.4 times subscribed and the former diabetes unit becoming independent.

What does the reset change?

The portfolio change removes Medtronic's remaining MiniMed equity stake and shifts the earnings story toward cardiovascular, surgical and neuroscience growth. The first-quarter figures provide the latest operating benchmark: revenue growth was 13.70 percent, while operating margin was 18.00 percent for the quarter ended July 31, 2026. Piper Sandler kept a Neutral rating and an USD 85.00 price target on October 14, 2026, citing the need for stronger growth drivers, as Investing.com reported.

Next reporting date is November 17

The next scheduled reporting date is November 17, 2026, before the market opens, according to Yahoo Finance. Analysts listed on the calendar expect second-quarter fiscal 2027 earnings of USD 1.33 per share. That report will show whether the first-quarter acceleration continued after the MiniMed separation.

Stock trades below the Xetra close

Medtronic stock was trading at EUR 83.20 at Lang & Schwarz on October 20, 2026 at 10:05 a.m. CEST, down 1.35 percent versus the Xetra close of October 19, 2026 at EUR 84.34. The primary listing is on the NYSE, where the October 19, 2026 last price was USD 92.77, while market capitalization stood at USD 118.7 billion.

The further course of trading is shown by the continuously updated real-time quote of Medtronic stock.